Histopathologic analysis of suspected amiodarone hepatotoxicity

Human Pathology

Volumn 21, Issue 1, 1990, Pages 59-67

  Lewis, James H ^a,b,c   Mullick, Florabel ^a,b,c   Ishak, Kamal G ^a,b,c   Ranard, Richard C ^a,b,c   Ragsdale, Bruce ^a,b,c   Perse, Randy M ^a,b,c   Rusnock, Eileen J ^a,b,c   Wolke, Anita ^a,b,c   Benjamin, Stanley B ^a,b,c   Seeff, Leonard B ^a,b,c   Zimmerman, Hyman J ^a,b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

amiodarone hepatotoxicity; drug induced liver disease; pseudo alcoholic hepatitis

Indexed keywords

AMIODARONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS; HISTOLOGY; HUMAN; HUMAN CELL; LIVER INJURY; LIVER TOXICITY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMAN; LIVER; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGE;

EID: 0025176785     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(90)90076-H     Document Type: Article

References (53)

1. Amiodarone
2. Amiodarone-associated phospholipidosis and fibrosis of the liver: Light immunohistochemical, and electron microscopic studies
3. Amiodarone hepatotoxicity: A clinicopathologic study of five patients
4. Amiodarone and the liver
5. Amiodarone hepatotoxicity
6. Chronic liver disease after low daily doses of amiodarone. Report of three cases
7. Amiodarone hepatotoxicity: Biochemical and histopathologic correlations
8. Hepatic effects of amiodarone
9. Amiodarone hepatotoxicity simulating alcoholic liver disease
10. Amiodarone for control of sustained ventricular tachyarrythmia: Clinical and electrophysiologic effects in 51 patients
11. Amiodarone: Clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias
12. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrythmias
13. Neuropathy and fatal hepatitis in a patient receiving amiodarone
14. Fatal hepatic failure and encephalopathy associated with amiodarone therapy
15. Increased hepatic density and phospholipidosis due to amiodarone
16. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity
17. Clinical and morphologic effects of amiodarone on the liver
18. Hepatopathie aigue du a l'amiodarone. Etude d'un cas et revue de la litterature
19. Hepatotoxicity of amiodarone
20. Probably early acute hepatitis with parenteral amiodarone
21. Granular cells as a marker of early amiodarone hepatotoxicity: A pathological and analytical study
22. Fatal amiodarone hepatotoxicity
23. Amiodarone-induced hepatic phospholipidosis: A morphologic alteration independent of pseudoalcoholic liver disease
24. Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
25. Methotrexate-induced chronic liver injury: Guidelines for detection and prevention
26. The liver
27. Alcoholic foamy degeneration—A pattern of acute alcoholic injury of the liver
28. Giant mitochondria in hepatocytes. A diagnostic hint for alcoholic liver disease
29. Alcoholic steatonecrosis. I. Relationship between severity of hepatic disease and presence of Mallory bodies in the liver
30. The SGOT/SGPT ratio—An indicator of alcoholic liver disease
31. Drug-induced generalized phospholipidosis
32. Drug-induced phospholipidoses
33. NMR-studies on the molecular basis of drug-induced phospholipidosis. II. Interaction between several amphophilic drugs and phospholipids
34. Amiodarone—An inhibitor of 5 phospholipase activity: A comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine
35. Amiodarone-induced phospholipidosis in rat alveolar macrophages
36. In vitro inhibition of phospholipase A1 of rat lung by amiodarone and desethylamiodarone
37. Amiodarone-induced lysosomal inclusions in primary cultures of human hepatocytes
38. Studies on drug-induced lipidosis: VII. Effects of bisbeta-diethylaminoethylether of hexestrol, chloroquine, homochlorocyclizine, prenylamine and diazacholesterol on the lipid composition of rat liver and kidney
39. Morphological and biochemical changes in the liver of various species in experimental phospholipidosis after diethylaminoethoxyhexestrol treatment
40. Perhexiline maleate-induced cirrhosis
41. Liver damage associated with perhexileine maleate
42. Recovery from amiodarone-induced lipidosis in laboratory animals A toxicological study
43. Amiodarone-induced cornea verticillata
44. Diffuse alveolar damage syndrome associated with amiodarone therapy
45. Amiodarone-induced hepatic phospholipidosis: Correlation of morphological and biochemical findings in an animal model
46. Impaired oxidation of debrisoquine in patients with perhexiline liver injury
47. Reye's syndrome-like illness in a patient receiving amiodarone
48. Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases
49. Pseudocyanotic pigmentation of the skin by amiodarone: A light and electron microscopic study
50. Amiodarone keratopathy: Drug-induced lipid storage disease
51. Neuromyopathy during chronic amiodarone treatment
52. Multi-organ toxicity associated with amiodarone-induced hepatic dysfunction